Holdings

Vestal Point Capital, LP

As of Sep 30, 2026, Vestal Point Capital, LP reported 55 positions worth US$3.58B. Largest: Abivax SA, Neurocrine Biosciences, Inc. and BioMarin Pharmaceutical Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Abivax SA3.96MUS$392M+1.61MSep 30, 2026
Neurocrine Biosciences, Inc.2.5MUS$355M+620KSep 30, 2026
BioMarin Pharmaceutical Inc.5.53MUS$332M−500KSep 30, 2026
Arrowhead Pharmaceuticals, Inc.4.82MUS$315M+3.24MSep 30, 2026
Insmed Incorporated2.73MUS$311M+2.48MSep 30, 2026
United Therapeutics Corporation475KUS$257M+40,000Sep 30, 2026
Nurix Therapeutics, Inc.7.03MUS$167M−1.02MSep 30, 2026
Tarsus Pharmaceuticals, Inc.2.03MUS$160M+984KSep 30, 2026
Enliven Therapeutics, Inc.3.23MUS$148M−775KSep 30, 2026
Disc Medicine, Inc.1.64MUS$107M+85,000Sep 30, 2026